Effect of Genistein Supplementation on the Progression of Neoplasms and the Level of the Modified Nucleosides in Rats With Mammary Cancer

In Vivo. 2021 Jul-Aug;35(4):2059-2072. doi: 10.21873/invivo.12475.

Abstract

Background/aim: The aim of the study was to assess the impact of nano-, micro-, and macro-sized-genistein on the growth and development of neoplasms in rats with mammary cancer. Additionally, the effect on the kinetics of changes (9-11-17-20 week of a rat's life) in the levels of methyl derivatives: 1-methyladenine, 3-methyladenine, 7-methylguanine, 1-methylguanine, 1-methyladenosine, 7-methylguanosine, O-methyl-guanosine and N6-methyl-2'-deoxyguanosine in the urine of rats was analyzed.

Materials and methods: Female Sprague-Dawley rats divided into 4 groups were used in the study. Animals were fed only a control diet or diets supplemented with the nano-, micro- and macro-sized genistein. To induce the mammary adenocarcinoma, rats were treated with 7,12-dimethylbenz[a]anthracene (DMBA). Modified nucleosides were determined by a high-performance liquid chromatography coupled to mass spectrometry method (LC-MS/MS).

Results: The supplementation of the diet of animals with genistein resulted in an increase in the excretion of methylated derivatives in the urine of rats. In the animals receiving standard diet, the levels of methyl derivatives increased during the study or remained relatively low. In the case of animals whose diet was supplemented with the various forms of genistein, the levels of methylated derivatives were very high from the beginning.

Conclusion: High levels of methyl derivatives can influence carcinogenesis.

Keywords: Genistein; macroparticles; nanoparticles.

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Chromatography, Liquid
  • Dietary Supplements
  • Female
  • Genistein*
  • Mammary Neoplasms, Experimental* / chemically induced
  • Mammary Neoplasms, Experimental* / drug therapy
  • Nucleosides
  • Rats
  • Rats, Sprague-Dawley
  • Tandem Mass Spectrometry

Substances

  • Nucleosides
  • 9,10-Dimethyl-1,2-benzanthracene
  • Genistein